IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JAMES MATTHEW MOBLEY

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1184018285
CMS profile
6512221
Location
PLANO, TX

General Payments · PY2022–2024

$2,007.74

  • Reported across 98 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,398.94

69 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Hematology & Oncology TX All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,398.94 69

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $191.83 10
NOVARTIS PHARMACEUTICALS CORPORATION $167.54 10
E.R. Squibb & Sons, L.L.C. $108.24 6
Acerta Pharma LLC $80.03 4
Astellas Pharma US Inc $71.42 3
Incyte Corporation $65.79 3
JAZZ PHARMACEUTICALS INC. $53.60 2
Adaptive Biotechnologies Corporation $46.70 2
EMD Serono, Inc. $46.36 2
PFIZER INC. $42.30 2
Kite Pharma, Inc. $40.30 2
Takeda Pharmaceuticals U.S.A., Inc. $39.88 2
Regeneron Healthcare Solutions, Inc. $39.21 2
Mirati Therapeutics, Inc. $38.69 2
Karyopharm Therapeutics Inc. $38.67 2
Bayer HealthCare Pharmaceuticals Inc. $38.60 2
PharmaEssentia USA Corporation $33.88 1
BeiGene USA, Inc. $31.83 1
Daiichi Sankyo Inc. $26.75 1
Janssen Biotech, Inc. $25.54 1
Stemline Therapeutics Inc. $24.77 1
GENZYME CORPORATION $24.02 1
EISAI INC. $22.00 1
Genmab U.S., Inc. $21.84 1
Exelixis Inc. $18.16 1
Legend Biotech USA Inc. $15.90 1
GlaxoSmithKline, LLC. $15.85 1
SOBI, INC $15.64 1
ABBVIE INC. $13.60 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $240.26 9
PY2023 $368.54 20
PY2024 $1,398.94 69

Payment records · PY2024 (69)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.60 08/14/2024 Food and Beverage Undisputed 01/23/2026 1105048804 CMS
Adaptive Biotechnologies Corporation $22.45 03/27/2024 Food and Beverage Undisputed 01/23/2026 1150259966 CMS
Adaptive Biotechnologies Corporation $24.25 07/15/2024 Food and Beverage Undisputed 01/23/2026 1150259968 CMS
Astellas Pharma US Inc $25.24 03/01/2024 Food and Beverage Undisputed 01/23/2026 1139295556 CMS
Astellas Pharma US Inc $21.69 09/20/2024 Food and Beverage Undisputed 01/23/2026 1139418331 CMS
Astellas Pharma US Inc $24.49 10/07/2024 Food and Beverage Undisputed 01/23/2026 1139428822 CMS
AstraZeneca Pharmaceuticals LP $19.20 01/12/2024 Food and Beverage Undisputed 01/23/2026 1105319054 CMS
AstraZeneca Pharmaceuticals LP $16.78 08/01/2024 Food and Beverage Undisputed 01/23/2026 1105537477 CMS
AstraZeneca Pharmaceuticals LP $17.34 08/28/2024 Food and Beverage Undisputed 01/23/2026 1104453316 CMS
AstraZeneca Pharmaceuticals LP $26.71 09/09/2024 Food and Beverage Undisputed 01/23/2026 1104643863 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.70 07/10/2024 Food and Beverage Undisputed 01/23/2026 1086264989 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.90 12/01/2024 Food and Beverage Undisputed 01/23/2026 1086251470 CMS
BeiGene USA, Inc. $31.83 11/15/2024 Food and Beverage Undisputed 01/23/2026 1120855506 CMS
Daiichi Sankyo Inc. $26.75 10/23/2024 Food and Beverage Undisputed 01/23/2026 1089458298 CMS
E.R. Squibb & Sons, L.L.C. $16.83 01/19/2024 Food and Beverage Undisputed 01/23/2026 1101360214 CMS
E.R. Squibb & Sons, L.L.C. $18.98 05/22/2024 Food and Beverage Undisputed 01/23/2026 1101360252 CMS
E.R. Squibb & Sons, L.L.C. $17.70 07/12/2024 Food and Beverage Undisputed 01/23/2026 1101360264 CMS
E.R. Squibb & Sons, L.L.C. $17.84 07/31/2024 Food and Beverage Undisputed 01/23/2026 1101360266 CMS
E.R. Squibb & Sons, L.L.C. $16.96 08/30/2024 Food and Beverage Undisputed 01/23/2026 1101360280 CMS
E.R. Squibb & Sons, L.L.C. $19.93 11/20/2024 Food and Beverage Undisputed 01/23/2026 1101360304 CMS
Eisai Inc. $22.00 06/11/2024 Food and Beverage Undisputed 01/23/2026 1110750912 CMS
EMD Serono, Inc. $30.82 01/23/2024 Food and Beverage Undisputed 01/23/2026 1120226431 CMS
EMD Serono, Inc. $15.54 11/22/2024 Food and Beverage Undisputed 01/23/2026 1120273014 CMS
Exelixis Inc. $18.16 02/12/2024 Food and Beverage Undisputed 01/23/2026 1138559050 CMS
Genmab U.S., Inc. $21.84 09/25/2024 Food and Beverage Undisputed 01/23/2026 1126827472 CMS
GENZYME CORPORATION $24.02 02/23/2024 Food and Beverage Undisputed 01/23/2026 1139901420 CMS
GlaxoSmithKline, LLC. $15.85 07/08/2024 Food and Beverage Undisputed 01/23/2026 1116520038 CMS
Incyte Corporation $20.83 02/19/2024 Food and Beverage Undisputed 01/23/2026 1141197707 CMS
Incyte Corporation $27.84 06/01/2024 Food and Beverage Undisputed 01/23/2026 1141249260 CMS
Incyte Corporation $17.12 06/04/2024 Food and Beverage Undisputed 01/23/2026 1141274998 CMS
Janssen Biotech, Inc. $25.54 11/01/2024 Food and Beverage Undisputed 01/23/2026 1078749174 CMS
JAZZ PHARMACEUTICALS INC. $28.30 05/10/2024 Food and Beverage Undisputed 01/23/2026 1150203204 CMS
JAZZ PHARMACEUTICALS INC. $25.30 08/21/2024 Food and Beverage Undisputed 01/23/2026 1150203202 CMS
Karyopharm Therapeutics Inc. $18.69 08/05/2024 Food and Beverage Undisputed 01/23/2026 1145530997 CMS
Karyopharm Therapeutics Inc. $19.98 11/06/2024 Food and Beverage Undisputed 01/23/2026 1145531001 CMS
Kite Pharma, Inc. $15.30 07/24/2024 Food and Beverage Undisputed 01/23/2026 1128613243 CMS
Kite Pharma, Inc. $25.00 10/30/2024 Food and Beverage Undisputed 01/23/2026 1128613259 CMS
Legend Biotech USA Inc. $15.90 08/20/2024 Food and Beverage Undisputed 01/23/2026 1131691644 CMS
Merck Sharp & Dohme LLC $21.10 03/11/2024 Food and Beverage Undisputed 01/23/2026 1141623565 CMS
Merck Sharp & Dohme LLC $19.72 05/15/2024 Food and Beverage Undisputed 01/23/2026 1141623567 CMS
Merck Sharp & Dohme LLC $20.91 05/24/2024 Food and Beverage Undisputed 01/23/2026 1141843291 CMS
Merck Sharp & Dohme LLC $15.53 07/29/2024 Food and Beverage Undisputed 01/23/2026 1141623573 CMS
Merck Sharp & Dohme LLC $17.68 08/26/2024 Food and Beverage Undisputed 01/23/2026 1141623575 CMS
Merck Sharp & Dohme LLC $19.37 09/11/2024 Food and Beverage Undisputed 01/23/2026 1141623571 CMS
Merck Sharp & Dohme LLC $18.56 10/16/2024 Food and Beverage Undisputed 01/23/2026 1141919626 CMS
Merck Sharp & Dohme LLC $18.64 10/28/2024 Food and Beverage Undisputed 01/23/2026 1141843293 CMS
Merck Sharp & Dohme LLC $18.42 11/25/2024 Food and Beverage Undisputed 01/23/2026 1141623569 CMS
Merck Sharp & Dohme LLC $21.90 12/11/2024 Food and Beverage Undisputed 01/23/2026 1141623563 CMS
Mirati Therapeutics, Inc. $19.88 04/26/2024 Food and Beverage Undisputed 01/23/2026 1117166181 CMS
Mirati Therapeutics, Inc. $18.81 07/26/2024 Food and Beverage Undisputed 01/23/2026 1117166173 CMS
Novartis Pharmaceuticals Corporation $14.71 01/05/2024 Food and Beverage Undisputed 01/23/2026 1086990930 CMS
Novartis Pharmaceuticals Corporation $20.73 01/31/2024 Food and Beverage Undisputed 01/23/2026 1086990936 CMS
Novartis Pharmaceuticals Corporation $20.14 02/26/2024 Food and Beverage Undisputed 01/23/2026 1086990940 CMS
Novartis Pharmaceuticals Corporation $15.34 02/28/2024 Food and Beverage Undisputed 01/23/2026 1086990938 CMS
Novartis Pharmaceuticals Corporation $12.89 03/27/2024 Food and Beverage Undisputed 01/23/2026 1086990946 CMS
Novartis Pharmaceuticals Corporation $19.79 04/24/2024 Food and Beverage Undisputed 01/23/2026 1086990948 CMS
Novartis Pharmaceuticals Corporation $15.12 09/04/2024 Food and Beverage Undisputed 01/23/2026 1086990956 CMS
Novartis Pharmaceuticals Corporation $19.55 09/13/2024 Food and Beverage Undisputed 01/23/2026 1086990966 CMS
Novartis Pharmaceuticals Corporation $15.19 09/18/2024 Food and Beverage Undisputed 01/23/2026 1086990962 CMS
Novartis Pharmaceuticals Corporation $14.08 10/02/2024 Food and Beverage Undisputed 01/23/2026 1086990958 CMS
PFIZER INC. $16.94 05/06/2024 Food and Beverage Undisputed 01/23/2026 1131549258 CMS
PFIZER INC. $25.36 06/24/2024 Food and Beverage Undisputed 01/23/2026 1131326227 CMS
PharmaEssentia USA Corporation $33.88 03/04/2024 Food and Beverage Undisputed 01/23/2026 1137306683 CMS
Regeneron Healthcare Solutions, Inc. $20.32 09/27/2024 Food and Beverage Undisputed 01/23/2026 1114116976 CMS
Regeneron Healthcare Solutions, Inc. $18.89 12/04/2024 Food and Beverage Undisputed 01/23/2026 1114116978 CMS
SOBI, INC $15.64 04/19/2024 Food and Beverage Undisputed 01/23/2026 1141419870 CMS
Stemline Therapeutics Inc. $24.77 01/05/2024 Food and Beverage Undisputed 01/23/2026 1142960613 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.21 09/18/2024 Food and Beverage Undisputed 01/23/2026 1144963330 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.67 11/08/2024 Food and Beverage Undisputed 01/23/2026 1144963332 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.